Ratio Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Ratio Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers (NCT07774650) | Ratio Therapeutics, Inc. | 2026-07-08 |
| Actinium Therapy for Late-stage Aggressive Sarcomas (NCT07156565) | Ratio Therapeutics, Inc. | 2025-11-12 |
| Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer (NCT05773703) | Ratio Therapeutics, Inc. | 2022-12-08 |
Track Ratio Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.